Skip to content Skip to footer

Loading Results

Pharma emerging markets 2.0: How emerging markets are driving the transformation of the pharmaceutical industry

Apr 21, 2015

Pharmaceutical companies face a major challenge that threatens reimbursement and value capture: The potential disruption from real world evidence (RWE) as a factor in evaluating new drugs. The emergence of health technology assessment practices today makes it still more difficult to achieve attractive reimbursement value for newly launched products.

Contact us

PwC office

Reсeption, PwC Russia

Tel: +7 (495) 967 6000

Follow us